Evidence map›Paper›PMID 23175834›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

A polymorphic microsatellite repeat within the ECE-1c promoter is involved in transcriptional start site determination, human evolution, and Alzheimer's disease.

Yaosi Li, Kerstin Seidel, Peter Marschall, Michael Klein, Antonia Hope, Jens Schacherl, Jennifer Schmitz, Mario Menk, Jan H Schefe, Jana Reinemund and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Nascent Aβ42 Fibrillization in Synaptic Endosomes Precedes Plaque Formation in a Mouse Model of Alzheimer's-like β-Amyloidosis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  2. Article
  3. Article
  4. STRs: Ancient Architectures of the Genome beyond the Sequence.Journal of molecular neuroscience : MN · 2021
    Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 7 institutions in 4 countries.

Yaosi LiCenter for Cardiovascular Research/Institute of Pharmacology, Charité-Universitätsmedizin Berlin, 10115 Berlin, Germany.
Kerstin Seidel
Peter Marschall
Michael Klein
Antonia Hope
Jens Schacherl
Jennifer Schmitz
Mario Menk
Jan H Schefe
Jana Reinemund
Rebecca Hugel
Peter Walden
Andreas Schlosser
Rudolf Volkmer
Julia Schimkus
Heike Kölsch
Wolfgang Maier
Johannes Kornhuber
Lutz Frölich
Sabrina Klare
Sebastian Kirsch
Kristin Schmerbach
Sylvia Scheele
Ulrike Grittner
Frank Zollmann
Petra Goldin-Lang
Oliver Peters
Ulrich Kintscher
Thomas Unger
Heiko Funke-Kaiser
Institute of Pharmacology · CZCharité - Universitätsmedizin Berlin · DEUniversity of Bonn · DECentral Institute of Mental Health · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEInstitute of Immunology · HRPalmetto Hematology Oncology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic factors strongly contribute to the pathogenesis of sporadic Alzheimer's disease (AD). Nevertheless, genome-wide association studies only yielded single nucleotide polymorphism loci of moderate importance. In contrast, microsatellite repeats are functionally less characterized structures within our genomes. Previous work has shown that endothelin-converting enzyme-1 (ECE-1) is able to reduce amyloid β content. Here we demonstrate that a CpG-CA repeat within the human ECE-1c promoter is highly polymorphic, harbors transcriptional start sites, is able to recruit the transcription factors poly(ADP-ribose) polymerase-1 and splicing factor proline and glutamine-rich, and is functional regarding haplotype-specific promoter activity. Furthermore, genotyping of 403 AD patients and 444 controls for CpG-CA repeat length indicated shifted allelic frequency distributions. Sequencing of 245 haplotype clones demonstrated that the overall CpG-CA repeat composition of AD patients and controls is distinct. Finally, we show that human and chimpanzee [CpG](m)-[CA](n) ECE-1c promoter repeats are genetically and functionally distinct. Our data indicate that a short genomic repeat structure constitutes a novel core promoter element, coincides with human evolution, and contributes to the pathogenesis of AD.

Indexed as

Biological EvolutionAlzheimer DiseaseAnimalsAspartic Acid EndopeptidasesBlotting, WesternCardiovascular DiseasesChromatography, GelDNAElectrophoretic Mobility Shift AssayEndothelin-Converting EnzymesGenotypeHumansMetalloendopeptidasesMicrosatellite RepeatsNuclease Protection AssaysPan troglodytesAspartic Acid EndopeptidasesDNAECE1 protein, humanEndothelin-Converting EnzymesMetalloendopeptidasesPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesRNA

Identifiers

PMID23175834
PMCPMC6621774
OpenAlexW1983987469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.